Rafferty Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-104,985
Closed -$1.3M 1160
2024
Q4
$1.3M Sell
104,985
-9,460
-8% -$108K ﹤0.01% 742
2024
Q3
$1.3M Sell
114,445
-69,861
-38% -$701K ﹤0.01% 738
2024
Q2
$1.32M Sell
184,306
-341,285
-65% -$2.61M ﹤0.01% 752
2024
Q1
$3.52M Buy
525,591
+144,432
+38% +$994K 0.01% 538
2023
Q4
$2.48M Buy
381,159
+187,280
+97% +$1.21M 0.01% 622
2023
Q3
$1.83M Sell
193,879
-10,544
-5% -$127K 0.01% 634
2023
Q2
$2.86M Buy
204,423
+27,602
+16% +$470K 0.02% 542
2023
Q1
$3.32M Sell
176,821
-142,723
-45% -$2.34M 0.02% 485
2022
Q4
$4.4M Buy
319,544
+145,249
+83% +$2.22M 0.04% 404
2022
Q3
$3.33M Buy
174,295
+52,226
+43% +$952K 0.04% 398
2022
Q2
$1.86M Sell
122,069
-93,902
-43% -$1.39M 0.02% 489
2022
Q1
$4.4M Buy
215,971
+36,009
+20% +$733K 0.03% 416
2021
Q4
$5.25M Buy
179,962
+63,572
+55% +$1.82M 0.03% 376
2021
Q3
$2.51M Buy
116,390
+34,783
+43% +$840K 0.02% 562
2021
Q2
$2.09M Buy
+81,607
New +$1.74M 0.01% 673

Other funds holding CDMO

Rafferty Asset Management's CDMO Position: Q1 2025 in Review

Rafferty Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 104,985 shares — an estimated $1.3M sold.

Rafferty Asset Management first reported a position in CDMO in Q2 2021 and held it in 15 quarters. The position peaked at $5.25M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Rafferty Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 104,985 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.3M.
  • Rafferty Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Rafferty Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $5.25M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Rafferty Asset Management's 13F filing for Q1 2025, filed 14 May 2025.